期刊文献+

MMP-7在IPF中的水平及意义 被引量:5

The level and significance of MMP-7 in the IPF
下载PDF
导出
摘要 目的研究血清MMP-7在IPF患者中的变化,探讨其在肺纤维化患者发病中的作用。方法收集11例IPF患者血清为实验组,收集10例健康成人血清为对照组。采用酶联免疫吸附法(ELISA)测定血清MMP-7含量,并与肺功能、动脉血气分析、呼吸困难程度进行分析。结果①IPF患者肺功能轻中度组血清MMP-7浓度(41.54±10.11)ng/mL及肺功能重度组血清MMP-7浓度(61.42±10.96)ng/mL,高于正常对照组血清MMP-7浓度(26.57±15.89)ng/mL,差异有统计学意义(P<0.05)。肺功能重度组血清MMP-7浓度高于肺功能轻中度组,差异有统计学意义(P<0.05)。②IPF患者血清MMP-7水平与动脉PaO2呈负相关(rs=-0.623,P=0.041),与呼吸困难严重程度呈正相关(rs=0.684,P=0.02),而与P(A-a)O2、PaCO2及HCO3-浓度无明显相关性(P>0.05)。结论①MMP-7可能参与了IPF的发病过程;②MMP-7可作为IPF严重程度及预后的一项参考指标。 Objective To study the changes of MMP -7 in the serum of IPF patients, and further to make clear the pathogenesis of MMP -7 in IPF. Methods The concentration of serum MMP -7 from 11 IPF patients and 10 normal control were analyzed with ELISA, while the lung function, arterial blood gases and the severity of dyspnea were detected. Results ①The MMP -7 concentrations from patients with mild to moderate lung function injury were 41.54±10.11 ng/mL and the ones from patients with severe lung function injury were 61.42±10.96 ng/mL, which were higher than those(26.57±15.89) ng/mL of the normal control group, and the difference were statistically significant ( P 〈 0.05 ) ; MMP - 7 concentrations from the group of severe lung function injury of IPF were higher than those from the group of mild to moderate lung function injury, and the difference was statistically significant ( P 〈 0. 05 ). ②The MMP-7 level showed a negative correlation( rs=-0. 623 ,P = 0. 041 ) with the PaO2 and positive correlation( r, = 0. 684 ,P = 0.02) with dyspnea severity, and no significant correlation with the concentration of P( A -a)O2 ,PaCO2 and HCO3 -. Conclusion ①MMP -7 may be involved in the path-ogenesis of IPF. ②MMP -7 can be as a reference for severity and prognosis of IPF.
出处 《遵义医学院学报》 2012年第5期400-403,共4页 Journal of Zunyi Medical University
基金 遵义汇川区科技局基金资助项目(NO:209.001.122.09)
关键词 IPF MMP-7 肺功能 动脉血气分析 呼吸困难 IPF MMP - 7 lung function arterial blood gas analysis dyspnea
  • 相关文献

参考文献12

  • 1li M, Yamamoto H, Adachi Y,et al. Role of Matrix Metal-loproteinase -7( Matrilysin) in Human Cancer Invasion,Apoptosis,Growth,and Angiogenesis [ J]. Exp Bio Med,2006, 231(1) :20 -27.
  • 2Rosas I 0, Richards T J, Konishi K, et al. MMP - 1 andMMP-7 as potential peripheral blood biomarkers in idio-pathic pulmonary fibrosis[ J]. PLos Med,2008 ,5(4) ;623-633.
  • 3周乐飞,姜莉,李振华,康健.特发性肺纤维化和结节病患者基质金属蛋白酶的变化及其临床意义[J].中华结核和呼吸杂志,2010,33(6):441-444. 被引量:8
  • 4杨炳辉,祝墦珠.全科医学概论[M].第3版.北京:人民卫生出版社,2011. 212.
  • 5Raghu G, Collard H R,Egan J J, et al. An official ATS/ERS/JRS/ALAT statement : idiopat hie pulmonary fibro-sis :evidencebased guidelines for diagnosis and managemnt[J]. Am J Respir Crit Care Med,2011 ,183 :788 - 824.
  • 6Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007[J]. CA Cancer J Clin, 2007 ,57 (1):43 - 66.
  • 7Swee M,Wilson C L,Wang Y,et al. Matrix metalloprotein-ase -7( matrilysin) controls neut rophil egress by generatinchemokine gradients [ J] . J Leukoc Biol,2008,83 ( 1 ):1404- 1412.
  • 8赵亚东,李振华,张中和,张梅英,王昆,阎雪,周红梅.Wnt/β-连环蛋白信号对人胚肺成纤维细胞趋化性及基质金属蛋白酶7的影响[J].中华内科杂志,2010,49(9):798-800. 被引量:1
  • 9McKeown S,Richter AG,0 Kane C,et al. MMP expressionand abnormal lung perm eability are important determi-nants of outcome in IPF[ J] . Eur Respir J,2009 ,33 ( 1 ):77 - 84.
  • 10Steel M P,Speer M C. Loyd J E,et al. Clinical and patho-losic features of familial intemtifial pneumonia[ J]. Am JRespir Crit Care Med,2005,172:1146 - 1152.

二级参考文献17

  • 1Rosas IO,Riehards TJ,Konishi K,et al.MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.PLoS Med,2008,5:e93.
  • 2American Thoracic Society,European Respiratory Society.American Thoracic Society/European Respiratory Society International Muhidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.This joint statement of the American Thoracic Society (ATS),and the European Respiratory Society (ERS) was adopted by the ATS board of directors,June 2001 and by the EBS Executive Committee,June 2001.Am J Bespir Crit Care Med,2002,165:277-304.
  • 3Zuo F,Karninski N,Eugui E,et al.Cene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.Prac Nail Acad Sci U S A,2002,99:6292-6297.
  • 4Selman M,Ruiz V,Cabrera S,et al.TIMP-1,-2,-3 and -4 in idiopathic pulmonary fibrosis.A prevailing nondegradative lung microenvironment? Am J Physioi Lung Cell Mol Physiol,2000,279:L562-L574.
  • 5Li Q,Park PW,Wilson CL,et al.Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.Cell,2002,111:635-646.
  • 6McGuire JK,Li Q,Parks WC.Matrilysin (matrix metalloproteinase-7) mediates E-cadhefin ectodomain shedding in injured lung epithelium Am J Pathol,2003,162:1831-1843.
  • 7Vuorinen K,Myll(a)rniemi M,Lammi L,et al.Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.APMIS,2007,115:969-975.
  • 8Cosgrove GP,Schwarz MI,Geraci MW,et al.Overexpression of matrix metalloproteinase-7 in pulmonary fibrosis.Chest,2002,121(3 Suppl):25S-26S.
  • 9Rosas IO,Ren P,Avila NA,et al.Early interstitial lung disease in familial pulmonary fibrosis.Am J Respir Crit Care Med,2007,176:698-705.
  • 10Steele MP,Speer MC,Loyd JE,et al.Clinical and pathologic features of familial interstitial pneumonia.Am J Respir Crit Care Med,2005,172:1146-1152.

共引文献7

同被引文献65

  • 1Yi-Lei Deng, Xian-Ze Xiong, Nan-Sheng Cheng Department of General Surgery, West China Hospital,Sichuan University, Chengdu 610041, China.Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists[J].Hepatobiliary & Pancreatic Diseases International,2012,11(5):467-478. 被引量:21
  • 2陈悦,陈超美,刘则渊,胡志刚,王贤文.CiteSpace知识图谱的方法论功能[J].科学学研究,2015,33(2):242-253. 被引量:6364
  • 3关立华,张淑兰.MMP-26在正常子宫内膜和子宫内膜癌组织中的表达[J].中华肿瘤防治杂志,2006,13(9):651-655. 被引量:7
  • 4李新霞,代华平,朱敏,庞宝森,马力,吕月平,王辰.转化生长因子-β_1 T869C G915C基因多态性与特发性肺纤维化的相关性研究[J].中国实用内科杂志,2007,27(13):1014-1016. 被引量:4
  • 5Olson A L, Swigris J J, Lezotte D C,et al. Mortality frompulmonary fibrosis increased in the United states from1992 to 2003[J]. Am J Respir Crit Care Med,2007,176(3):277 -284.
  • 6Battista G,Zompatori M,Fasano L,et al. Progressive wors-ening of idiopathic pulmonary fibrosis. High resolutioncomputed tomography ( HRCT ) study with functional cor-relations [ J ]. Radiol Med,2003,105(1 -2) :2-11.
  • 7Manali E D, Stathopoulos G T,Kollintza A,et al. TheMedical Research council chronic dyspnea score predictsthe survival of patients with idiopathic pulmonary fibrosis[J]. J Respir Med,2008,102(4) :586 -592.
  • 8Raghu G, Collard H R, Egan J J, et al. An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibosis :evidence - based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med,2011,183 (6) :788 -824.
  • 9Selman M,Ruiz V,Cabrera S,et al. TIMP 一 1,- 2 , 一 3 ,and -4 in idiopathic pulmonary fibrosis. A prevailing non-degradative lung microenvironment ? [ J ]. Am J PhysiolLung Cell Mol Physiol,2000,279(3) :562 -574.
  • 10Marchenko G N, Ratnikov B I, Rozanov D V,et al. Char-acterization of matrix metalloproteinase -26, a novel met-alloproteinase widely expressed in cancer cells of epithelialorigin[ J]. J Biol Chem,2001,356 (Pt 3) :705 -718.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部